Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission

Randy W Loftus1, Matthew K Muffly, Jeremiah R Brown

  • 1Department of Anesthesiology and Critical Care Medicine, Dartmouth–Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA. randy.loftus@hitchcock.org

Abstract

Insights

Anesthesia provider hands are a significant source of operating room bacterial contamination, increasing patient risk. Improved hand hygiene and environmental cleaning are crucial to prevent intraoperative transmission and improve patient outcomes.

Area of Science:

  • Healthcare-associated infections
  • Microbiology
  • Anesthesiology

Background:

  • Intraoperative bacterial transmission to IV stopcock sets is linked to increased patient mortality.
  • Bacterial contamination of anesthesia provider hands before patient contact may cause direct intraoperative transmission.

Purpose of the Study:

  • To investigate if contaminated anesthesia provider hands contribute to intraoperative bacterial transmission.
  • To assess the effectiveness of current intraoperative cleaning protocols.

Main Methods:

  • Analyzed 82 paired operative cases at a tertiary care center.
  • Used biotype analysis to compare bacteria from patient IV stopcock sets and the anesthesia environment with bacteria from anesthesia provider hands.
  • Evaluated potential pathogens in the anesthesia environment at the start of the second case to assess cleaning efficacy.

Main Results:

  • Provider-origin bacteria were found in 47% of IV stopcock set transmissions and 12% of anesthesia environment transmissions.
  • Intraoperative bacterial transmission to the IV stopcock set occurred in 11.5% of cases.
  • Attending anesthesiologist workload, patient age, and ICU discharge predicted non-provider-linked transmission.

Conclusions:

  • Contaminated anesthesia provider hands are a major source of bacterial contamination in the operating room environment and on patient IV stopcock sets.
  • Further research into postoperative environmental cleaning practices is recommended to identify additional sources of bacterial transmission.

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.6K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
379
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
200